Invitrogen has a total of 3118 patents globally, out of which 632 have been granted. Of these 3118 patents, only 2% patents of the portfolio are active. Europe is where Invitrogen has filed the maximum number of patents, followed by the USA and Japan. The USA seems to be the main focused R&D center and is also the origin country of Invitrogen.
Invitrogen is the subpart of Thermo Fisher Scientific was founded in the year 1987. Invitrogen Corporation provides essential life science technologies for disease research, drug discovery, and commercial bio-production. The company’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery.
Do read about some of the most popular patents of Invitrogen which have been covered by us in this report and also you can find Invitrogen’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Invitrogen’s patent portfolio.
How many patents does Invitrogen have?
Invitrogen has a total of 3118 patents globally. These patents belong to 1147 unique patent families. Out of 3118 patents, 75 patents are active.
How Many Patents did Invitrogen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Invitrogen Applications Filed | Invitrogen Patents Granted |
| 2022 | – | 1 |
| 2021 | 2 | 2 |
| 2020 | 3 | 1 |
| 2019 | 2 | 3 |
| 2018 | 2 | 4 |
| 2017 | 8 | 8 |
| 2016 | 6 | 7 |
| 2015 | 9 | 8 |
| 2014 | 3 | 15 |
| 2013 | 10 | 12 |
| 2012 | 3 | 15 |
| 2011 | 12 | 6 |
How many Invitrogen patents are Alive/Dead?
Worldwide Patents
How Many Patents did Invitrogen File in Different Countries?
Countries in which Invitrogen Filed Patents
| Country | Patents |
| Europe | 523 |
| United States Of America | 358 |
| Japan | 353 |
| Australia | 338 |
| Canada | 267 |
| Austria | 132 |
| Germany | 115 |
| China | 54 |
| New Zealand | 40 |
| Hong Kong (S.A.R.) | 28 |
| United Kingdom | 25 |
| Spain | 21 |
| Denmark | 16 |
| India | 14 |
| Singapore | 13 |
| Israel | 9 |
| Brazil | 8 |
| Korea (South) | 7 |
| Portugal | 5 |
| Mexico | 4 |
| Czech Republic | 2 |
| Russia | 2 |
| Italy | 2 |
| Argentina | 1 |
| South Africa | 1 |
| Philippines | 1 |
| Hungary | 1 |
| Finland | 1 |
| Cyprus | 1 |
| Norway | 1 |
| Latvia | 1 |
| Poland | 1 |
| Slovenia | 1 |
Where are Research Centres of Invitrogen Patents Located?
10 Best Invitrogen Patents
US6649138B2 is the most popular patent in the Invitrogen portfolio. It has received 687 citations so far from companies like Ventana Medical Systems, Fio Corporation, and INSERM.
Below is the list of 10 most cited patents of Invitrogen:
| Publication Number | Citation Count |
| US6649138B2 | 687 |
| US6814934B1 | 413 |
| US6682596B2 | 361 |
| US20040054155A1 | 338 |
| US20040171156A1 | 297 |
| US6500622B2 | 282 |
| US20040014956A1 | 244 |
| US20030119004A1 | 235 |
| US6720140B1 | 226 |
| US6630307B2 | 214 |
How many inventions of other companies were rejected due to Invitrogen patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Invitrogen invention. They couldn’t because Invitrogen had protected those before them.
Examiners at the USPTO referred 90 Invitrogen patents in 610 rejections (35 USC § 102 or 35 USC § 103 types).
The citing companies in the Invitrogen patent portfolio are Sarepta Therapeutics, Stratos Genomics Inc, and Siemens Healthcare.
List of the Companies whose Patents were rejected citing Invitrogen –
| Company | Number of Patent Applications that faced Rejection Citing Invitrogen Patents | Number of Rejections (102 & 103) |
| Sarepta Therapeutics | 4 | 8 |
| Stratos Genomics Inc | 4 | 7 |
| Siemens Healthcare Diagnostics Ltd | 3 | 15 |
| Src Inc | 3 | 8 |
| Medimmune | 3 | 7 |
| Sysmex Corporation | 3 | 10 |
| Dicerna Pharmaceuticals | 2 | 10 |
| Philips | 2 | 10 |
| Elwha Llc | 2 | 3 |
| Fujifilm | 2 | 2 |
Count of 102 and 103 Type Rejections based on Invitrogen Patents
Top Invitrogen Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US20100285490A1 | 29 |
| US6649138B2 | 19 |
| US20070037165A1 | 9 |
| US8198084B2 | 9 |
| US6500622B2 | 8 |
| US20040014956A1 | 8 |
| US6630307B2 | 7 |
| US20060199196A1 | 7 |
| US20100291548A1 | 7 |
| US20020004246A1 | 7 |
| US20080254482A1 | 7 |
| US20020028457A1 | 6 |
| US20020155507A1 | 6 |
| US7079241B2 | 5 |
| US20030099940A1 | 5 |
What Percentage of Invitrogen US Patent Applications were Granted?
Invitrogen (Excluding its subsidiaries) has filed 532 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 249 have been granted leading to a grant rate of 48.4%.
Below are the key stats of Invitrogen patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Invitrogen?
| Law Firm | Total Applications | Success Rate |
| Life Technologies Corporation | 414 | 49.88% |
| Sterne Kessler Goldstein & Fox Pllc | 34 | 60.00% |
| Fish & Richardson Pc | 7 | 28.57% |
| Intellevate Llc | 7 | 14.29% |
| Kilpatrick Townsend & Stockton Llp | 6 | 16.67% |
| Leydig Voit & Mayer Ltd | 6 | 16.67% |
| Foley & Lardner Llp | 5 | 60.00% |
| Choate Hall & Stewart Llp | 4 | 100.00% |
| Leydig Voit & Mayer Ltd | 4 | 75.00% |
| Morgan & Finnegan Transition Team | 3 | 100.00% |